Geron
GERN
#6280
Rank
NZ$1.44 B
Marketcap
NZ$2.27
Share price
3.15%
Change (1 day)
-66.31%
Change (1 year)

Geron (GERN) - Total debt

Total debt on the balance sheet as of September 2025 : NZ$0.21 Billion

According to Geron's latest financial reports the company's total debt is NZ$0.21 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Geron - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31NZ$0.21 B58.89%
2023-12-31NZ$0.13 B54.68%
2022-12-31NZ$87.81 M9.06%
2021-12-31NZ$80.51 M95.49%
2020-12-31NZ$41.18 M986.12%
2019-12-31NZ$3.79 M
2018-12-31N/A
2005-12-31NZ$0.08 M-98.23%
2004-12-31NZ$4.54 M-52.25%
2003-12-31NZ$9.52 M-80.85%
2002-12-31NZ$49.72 M18.54%
2001-12-31NZ$41.94 M-44.27%
2000-12-31NZ$75.27 M114.97%
1999-12-31NZ$35.01 M105.05%
1998-12-31NZ$17.07 M330.88%
1997-12-31NZ$3.96 M0.01%
1996-12-31NZ$3.96 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Eterna Therapeutics
ERNA
NZ$0.95 M-99.55%๐Ÿ‡บ๐Ÿ‡ธ USA
Gilead Sciences
GILD
NZ$43.17 B 20,357.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
NZ$0.68 B 223.56%๐Ÿ‡บ๐Ÿ‡ธ USA
Incyte
INCY
NZ$71.43 M-66.15%๐Ÿ‡บ๐Ÿ‡ธ USA
CTI BioPharma
CTIC
NZ$84.63 M-59.89%๐Ÿ‡บ๐Ÿ‡ธ USA